This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Shanghai Institute of Biological Products Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Hongyuan Liang
Introduction
Hongyuan Liang is a prominent inventor based in Shanghai, China. He is known for his significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work has the potential to impact the treatment of various diseases related to the HER3 antigen.
Latest Patents
Hongyuan Liang holds a patent for an anti-HER3 humanized monoclonal antibody. This innovative antibody binds to the HER3 antigen, demonstrating high affinity and biological activity while maintaining low immunogenicity. Its structural stability makes it a promising candidate for drug development aimed at preventing or treating HER3-related diseases.
Career Highlights
Liang's career is marked by his dedication to advancing medical science through innovative research. He is affiliated with the Shanghai Institute of Biological Products Co., Ltd., where he collaborates with other experts in the field to further enhance the efficacy of therapeutic antibodies.
Collaborations
Some of his notable coworkers include Aidong Qu and Fanhong Xu. Their collaborative efforts contribute to the ongoing research and development of groundbreaking biopharmaceuticals.
Conclusion
Hongyuan Liang's work exemplifies the intersection of innovation and healthcare. His contributions to the development of monoclonal antibodies are paving the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile